reg-wp-1

The Makings of ‘Regulatory-Grade' Real-World Data in Ophthalmology Using AI

Regulatory bodies, such as the Food and Drug Administration and the European Medicines Agency, are prioritizing real-world data (RWD) in clinical research and regulatory decision-making due to its potential to enhance drug development and improve patient outcomes.

Request your copy of this white paper to learn:

• The importance of artificial intelligence in transforming raw RWD into regulatory-grade evidence

• Key factors for ensuring the reliability and relevance of RWD when used in regulatory submissions

• How regulatory-grade data is being used in ophthalmology

Request a Copy

Please do not send any Protected Health Information (PHI) when submitting this form. This form is not encrypted and it is not a suitable method for transmitting PHI. Any PHI sent to Verana Health via this form is deemed to be authorized by the subject of the PHI.

dot-divider-line